[1]曹琳,张陈至立,姚孝明,等.罕见抗钌抗体所致甲状腺功能异常伴降钙素升高的患者1例并文献复习[J].国际内分泌代谢杂志,2023,43(04):341-344.[doi:10.3760/cma.j.cn121383-20220610-06024]
　Cao Lin,Zhang Chenzhili,Yao Xiaoming,et al.Rare anti-ruthenium antibody-induced thyroid dysfunction with hypercalcitoninemia: a case report and literature review[J].International Journal of Endocrinology and Metabolism,2023,43(04):341-344.[doi:10.3760/cma.j.cn121383-20220610-06024]

点击复制

罕见抗钌抗体所致甲状腺功能异常伴降钙素升高的患者1例并文献复习()

分享到：

参考文献/References:

[1] Favresse J,Burlacu MC,Maiter D,et al.Interferences with thyroid function immunoassays:clinical implications and detection algorithm[J].Endocr Rev,2018,39(5):830-850.DOI:10.1210/er.2018-00119.
[2] Bjerner J,Nustad K,Norum LF,et al.Immunometric assay interference:incidence and prevention[J].Clin Chem,2002,48(4):613-621.
[3] Holmes EW,Samarasinghe S,Emanuele MA,et al.Biotin interference in clinical immunoassays:a cause for concern[J].Arch Pathol Lab Med,2017,141(11):1459-1460.DOI:10.5858/arpa.2017-0107-LE.
[4] Piketty ML,Polak M,Flechtner I,et al.False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays:the problem of biotin intake and related interferences[J].Clin Chem Lab Med,2017,55(6):780-788.DOI:10.1515/cclm-2016-0606.
[5] Piketty ML,Souberbielle JC.Biotin:an emerging analytical interference[J].Ann Biol Clin(Paris),2017,75(4):366-368.DOI:10.1684/abc.2017.1252.
[6] Elston MS,Sehgal S,Du Toit S,et al.Factitious Graves' disease due to biotin immunoassay interference-a case and review of the literature[J].J Clin Endocrinol Metab,2016,101(9):3251-3255.DOI:10.1210/jc.2016-1971.
[7] Siddiqui U,Egnor E,Sloane JA.Biotin supplementation in MS clinically valuable but can alter multiple blood test results[J].Mult Scler,2017,23(4):619-620.DOI:10.1177/1352458516680751.
[8] Rulander NJ,Cardamone D,Senior M,et al.Interference from anti-streptavidin antibody[J].Arch Pathol Lab Med,2013,137(8):1141-1146.DOI:10.5858/arpa.2012-0270-CR.
[9] Hattori N,Ishihara T,Shimatsu A.Variability in the detection of macro TSH in different immunoassay systems[J].Eur J Endocrinol,2016,174(1):9-15.DOI:10.1530/EJE-15-0883.
[10] Loh TP,Kao SL,Halsall DJ,et al.Macro-thyrotropin:a case report and review of literature[J].J Clin Endocrinol Metab,2012,97(6):1823-1828.DOI:10.1210/jc.2011-3490.
[11] Després N,Grant AM.Antibody interference in thyroid assays:a potential for clinical misinformation[J].Clin Chem,1998,44(3):440-454.
[12] Sakata S,Nakamura S,Miura K.Autoantibodies against thyroid hormones or iodothyronine.Implications in diagnosis,thyroid function,treatment,and pathogenesis[J].Ann Intern Med,1985,103(4):579-589.DOI:10.7326/0003-4819-103-4-579.
[13] Sapin R,Agin A,Gasser F.Efficacy of a new blocker against anti-ruthenium antibody interference in the Elecsys free triiodothyronine assay[J].Clin Chem Lab Med,2007,45(3):416-418.DOI:10.1515/CCLM.2007.064.
[14] Heijboer AC,Ijzerman RG,Bouman AA,et al.Two cases of antiruthenium antibody interference in Modular free thyroxine assay[J].Ann Clin Biochem,2009,46(Pt 3):263-264.DOI:10.1258/acb.2009.008258.
[15] McKillop D,Thompson D,Sharpe P.Response to Heijboer et al.Ann Clin Biochem 2009; 46(3):263-4[J].Ann Clin Biochem,2009,46(Pt 5):428-429.DOI:10.1258/acb.2009.009144.
[16] Buijs MM,Gorgels JP,Endert E.Interference by antiruthenium antibodies in the Roche thyroid-stimulating hormone assay[J].Ann Clin Biochem,2011,48(Pt 3):276-281.DOI:10.1258/acb.2010.010160.
[17] Gessl A,Blueml S,Bieglmayer C,et al.Anti-ruthenium antibodies mimic macro-TSH in electrochemiluminescent immunoassay[J].Clin Chem Lab Med,2014,52(11):1589-1594.DOI:10.1515/cclm-2014-0067.
[18] Favresse J,Paridaens H,Pirson N,et al.Massive interference in free T₄ and free T₃ assays misleading clinical judgment[J].Clin Chem Lab Med,2017,55(4):e84-e86.DOI:10.1515/cclm-2016-0255.
[19] Suarez Rivero R,Ponce Lorenzo F,Díaz Torres J,et al.Falsely elevated thyroid-stimulating hormone value due to anti-ruthenium antibodies in a patient with primary hypothyroidism:a case report[J].Clin Chem Lab Med,2017,26:55(12):e273-e275.DOI:10.1515/cclm-2016-0515.